Herbert Smith Freehills Kramer (applicant) in Insulet v EOFLow (CoA, 22 December 2025)
| Date | 22 December 2025 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Application RoP262.1 (b) |
| Case number(s) | UPC_CoA_886/2025 |
| Registry reference | UPC-COA-0000886/2025 |
| Parties | Herbert Smith Freehills Kramer LLP (applicant) in Insulet Corporation v. EOFLow Co., Ltd. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
The judge-rapporteur of the Court of Appeal, sitting alone, grants Herbert Smith Freehills Kramer LLP access to Insulet Corporation’s Statement of Appeal and to a redacted version of EOFLow Co., Ltd.’s Statement of Response in appeal UPC_CoA_768/2024 (EP 4 201 327), decided by an order of 30 April 2025 on appeal from an order of the Milan Central Division. Three days after access was refused to a database publisher in Sumi Agro v Syngenta, the Court confirms that a law firm may be a member of the public within Rule 262.1(b) RoP, even where its request has a commercial dimension.
Question
Does a law firm seeking to understand a decision in order to advise its clients better have a sufficient interest in access to the pleadings, with no identified third party behind its request?
Decision
A law firm may be a member of the public within Rule 262.1(b) RoP, without any bona fide third party standing behind its application. Scrutinising how the Court handled the dispute enhances its ability to advise and serves the Court and its users (paragraphs 9 and 10). The interest relied on matches the general interest recognised in Ocado, which arises once a decision has been given (paragraph 11). Pursuing commercial interests does not preclude access, as the applicant does not commercialise the documents, and copyright is not an interest to be protected under Art. 45 UPCA (paragraphs 13 and 14). Personal data are redacted, and EOFLow’s confidentiality interests are preserved by access to the redacted version only (paragraphs 15 to 17). Insulet’s request that the applicant bear the costs is rejected (paragraphs 18 and 19).
Key points for practice
- The Court of Appeal draws the line between using case files to advise, which is allowed, and redistributing them commercially, which the Docket Navigator order of 19 December 2025 excluded (paragraph 13).
- Confining the request to redacted versions from the outset defuses confidentiality objections (paragraphs 16 and 17).
Provisions applied
- Agreement on a Unified Patent Court
- Art. 10(1), 45, 58 and 69(3)
- Rules of Procedure
- Rules 262.1, 262.2 and 262A
- Other provisions
- Regulation (EU) 2016/679.
- Case law cited
- Ocado, Court of Appeal, 10 April 2024, UPC_CoA_404/2023, Abbott v Powell Gilbert, Court of Appeal, UPC_CoA_480/2024 and UPC_CoA_481/2024, Docket Navigator v Sumi Agro and Syngenta, Court of Appeal, 19 December 2025, UPC_CoA_523/2024.
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: UPC Court of Appeal, Supplementary protection certificate (SPC), Biosimilar medicinal product, Launch at risk.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show, Pharmaceutical patents and the UPC: is the Court hostile to them?.
Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- defendantEOFLow Co., Ltd.22 decisions in the corpusFollow this party
- claimantHerbert Smith Freehills Kramer LLP (applicant) in Insulet CorporationFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Application RoP262.1 (b)
- Outcome (Dhenne Avocats summary)
- L’accès à la déclaration d’appel et à la version caviardée du mémoire en réponse est accordé au cabinet demandeur. Un cabinet d’avocats est un membre du public et la demande d’Insulet sur les frais est rejetée.
- Appeal
- Decision of the Court of Appeal.
- Instance
- Court of Appeal decision.
Patents mentioned
EP 4 201 327mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Docket Navigator (applicant) in Sumi Agro v Syngenta (CoA, 19 December 2025) cited in this record
- Abbott Diabetes Care v Powell Gilbert LLP (CoA, 9 January 2025) cited in this record
- Ocado Innovation v Autostore (CoA, 10 April 2024) cited in this record
- Ter Meer Steinmeister & Partner Patentanwälte mbB v 2seventy bio (CFI, 23 July 2026) cites this decision
- Franz Kaldewei v Bette (CFI, 23 July 2026) cites this decision
- Huawei Technologies v Quinn Emanuel Urquhart & Sullivan (CoA, 29 June 2026) cites this decision
- Huawei v MediaTek (CFI, UPC_CFI_1235/2025, 26 March 2026) cites this decision
- Huawei v MediaTek (CFI, UPC_CFI_1234/2025, 26 March 2026) cites this decision
- Gowling WLG v Merz Therapeutics (CFI, 19 February 2026) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 4 201 327Fluid delivery device with transcutaneous access tool, insertion mechanism and blood glucose monitoring for use therewith recorded proprietor: Insulet Corp | Mentioned in the analysis (role not qualified) Also mentioned in 25 other decision(s): EOFLOW v Insulet (CFI, 22 July 2025) · EOFLOW v Insulet (CoA, 18 March 2026) · EOFlow v Insulet (CoA, 26 February 2026) · EOFlow v Insulet (CoA, 4 February 2026) · EOFlow v Insulet (CoA, 29 January 2026) · Insulet v EOFLOW (CFI, 15 October 2025) · EOFLOW v Insulet (CFI, ORD_26828/2025, 5 June 2025) · EOFLOW v Insulet (CFI, 28 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.